RESUMO
The Southampton pneumococcal carriage study of children under 5 years old continued during the coronavirus disease 2019 (COVID-19) pandemic. Here, we present data from October 2018 to March 2023 describing prevalence of pneumococci and other pathobionts during the winter seasons before, during, and after the introduction of non-pharmaceutical interventions (NPIs) to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission. Nasopharyngeal swabs were collected from children attending outpatient clinics at a secondary care hospital and community healthcare sites. Pre-NPIs, in 2019/2020, the carriage prevalence of pneumococci at the hospital site was 32% (n = 161 positive/499 participants). During NPIs, this fell to 19% (n = 12/64), although based on fewer participants compared to previous years due to COVID-19 restrictions on health-care attendance. In 2021/2022, after NPIs had eased, prevalence rebounded to 33% (n = 15/46) [compared to NPIs period, χ2 (1, N = 110) =2.78, P = 0.09]. Carriage prevalence at community healthcare sites fell significantly from 27% (n = 127/470) in 2019/2020 to 19% during the NPI period (n = 44/228) in 2020/2021 [χ2 (1, N = 698) =4.95, P = 0.026]. No rebound was observed in 2021/2022 [19% (n = 56/288)]. However, in a multivariate logistic regression model, neither site had a significantly lower carriage prevalence during the NPI period compared to the post NPI period. A reduction in serotype diversity was observed in 2020/2021. Carriage of Haemophilus influenzae was particularly affected by NPIs with a significant reduction observed. In conclusion, among children under 5 years of age, transient, modest, and statistically non-significant alterations in carriage of both Streptococcus pneumoniae and H. influenzae were associated with SARS-CoV-2 NPIs.IMPORTANCEStreptococcus pneumoniae (the pneumococcus) continues to be a major contributor to global morbidity and mortality. Using our long-running pediatric study, we examined changes in pneumococcal carriage prevalence in nearly 3,000 children under the age of 5 years between the winters of 2018/2019 and 2022/2023. This period coincided with the severe acute respiratory syndrome coronavirus 2 pandemic and, in particular, the implementation of national strategies to limit disease transmission in the UK. We observed a transient reduction of both Streptococcus pneumoniae and Haemophilus influenzae in these populations during this period of non-pharmaceutical interventions. This aligned with the reduction in invasive pneumococcal disease seen in the UK and is therefore a likely contributor to this phenomenon.
Assuntos
COVID-19 , Portador Sadio , Infecções por Haemophilus , Haemophilus influenzae , Nasofaringe , Infecções Pneumocócicas , SARS-CoV-2 , Streptococcus pneumoniae , Humanos , COVID-19/epidemiologia , COVID-19/prevenção & controle , Pré-Escolar , Portador Sadio/epidemiologia , Portador Sadio/microbiologia , SARS-CoV-2/isolamento & purificação , Infecções Pneumocócicas/epidemiologia , Infecções Pneumocócicas/prevenção & controle , Infecções Pneumocócicas/microbiologia , Masculino , Feminino , Streptococcus pneumoniae/isolamento & purificação , Estudos Transversais , Lactente , Haemophilus influenzae/isolamento & purificação , Infecções por Haemophilus/epidemiologia , Infecções por Haemophilus/prevenção & controle , Infecções por Haemophilus/microbiologia , Nasofaringe/microbiologia , Nasofaringe/virologia , Reino Unido/epidemiologia , PrevalênciaRESUMO
INTRODUCTION: Pneumococcus remains a major cause of adult lower respiratory tract infections (LRTI). Few data exist on the relative contribution of serotypes included in pneumococcal vaccines to community-acquired pneumonia (CAP) and non-pneumonic (NP) LRTI. We measured the burden of all and vaccine-serotype pneumococcal respiratory infection following SARS-CoV-2 emergence to inform evidence-based vaccination policy. METHODS: A prospective cohort study at two Bristol hospitals (UK) including all adults age ≥ 18-years hospitalised with acute lower respiratory tract disease (aLRTD) from Nov2021-Nov2022. LRTI patients were classified as: a) radiographically-confirmed CAP (CAP+/RAD+), b) clinically-diagnosed CAP without radiological confirmation (CAP+/RAD-), or c) NP-LRTI. Pneumococcus was identified by blood culture, BinaxNOW™and serotype-specific urine antigen detection assays (UAD). RESULTS: Of 12,083 aLRTD admissions, 10,026 had LRTI and 2,445 provided urine: 1,097 CAP + RAD+; 207 CAP + RAD-; and 1,141 NP-LRTI. Median age was 71.1y (IQR57.9-80.2) and Charlson comorbidity index = 4 (IQR2-5); 2.7 % of patients required intensive care, and 4.4 % died within 30-days of hospitalisation. Pneumococcus was detected in 280/2445 (11.5 %) participants. Among adults aged ≥ 65y and 18-64y, 12.9 % (198/1534) and 9.0 % (82/911), respectively, tested pneumococcus positive. We identified pneumococcus in 165/1097 (15.0 %) CAP + RAD+, 23/207 (11.1 %) CAP + RAD-, and 92/1141 (8.1 %) NP-LRTI cases. Of the 280 pneumococcal cases, 102 (36.4 %) were due to serotypes included in PCV13 + 6C, 115 (41.7 %) in PCV15 + 6C, 210 (75.0 %) in PCV20 + 6C/15C and 228 (81.4 %) in PPV23 + 15C. The most frequently identified serotypes were 8 (n = 78; 27.9 % of all pneumococcus), 7F (n = 25; 8.9 %), and 3 (n = 24; 8.6 %). DISCUSSION: Among adults hospitalised with respiratory infection, pneumococcus is an important pathogen across all subgroups, including CAP+/RAD- and NP-LRTI. Despite 20-years of PPV23 use in adults ≥ 65-years and herd protection due to 17-years of PCV use in infants, vaccine-serotype pneumococcal disease still causes a significant proportion of LRTI adult hospitalizations. Direct adult vaccination with high-valency PCVs may reduce pneumococcal disease burden.
Assuntos
Infecções Comunitárias Adquiridas , Infecções Pneumocócicas , Pneumonia Pneumocócica , Infecções Respiratórias , Adulto , Humanos , Idoso , Sorogrupo , Pneumonia Pneumocócica/prevenção & controle , Estudos Prospectivos , Streptococcus pneumoniae , Infecções Pneumocócicas/epidemiologia , Infecções Pneumocócicas/prevenção & controle , Vacinas Pneumocócicas/uso terapêutico , Infecções Comunitárias Adquiridas/epidemiologia , Infecções Comunitárias Adquiridas/prevenção & controle , Reino Unido/epidemiologia , Vacinas ConjugadasRESUMO
Self-injurious thoughts have been associated with psychiatric morbidity and suicide. Little is known about psychosocial factors associated with self-injurious thoughts among people newly diagnosed with HIV in sub-Saharan Africa. This study examined whether food insufficiency, mental health symptoms, or social support were associated with recent self-injurious thoughts among people newly diagnosed with HIV in Mozambique. The sample included 2001 PLWH aged ≥ 18 newly diagnosed with HIV at 10 health clinics in Mozambique between April 2013 and June 2015. Data were collected at time of HIV diagnosis. Multivariable logistic regression modeled the association of social support, affective mental health symptom severity, somatic mental health symptom severity, and food insufficiency on recent self-injurious thoughts. Ten percent of respondents reported recent self-injurious thoughts, which was higher among women than men (11% vs 7%). In multivariable analyses, food insufficiency [adjusted odds ratio (aOR) 1.7 (95% CI 1.3, 2.2)], and low [aORvs no = 4.8, 95% CI 1.7, 13.4) and moderate/high affective symptom severity [aORvs no = 8.7, 95% CI 2.8, 27.6) were associated with greater odds of self-injurious thoughts. Interventions to address self-injurious thoughts should consider accompanying psychosocial stressors. Longitudinal research to examine mechanisms through which psychosocial stressors are associated with self-injurious thoughts is warranted.
Assuntos
Humanos , Masculino , FemininoRESUMO
Background: Concerning gaps in the HIV care continuum compromise individual and population health. We evaluated a combination intervention strategy (CIS) targeting prevalent barriers to timely linkage and sustained retention in HIV care in Mozambique. Methods and findings: In this cluster-randomized trial, 10 primary health facilities in the city of Maputo and Inhambane Province were randomly assigned to provide the CIS or the standard of care (SOC). The CIS included point-of-care CD4 testing at the time of diagnosis, accelerated ART initiation, and short message service (SMS) health messages and appointment reminders. A pre-post intervention 2-sample design was nested within the CIS arm to assess the effectiveness of CIS+, an enhanced version of the CIS that additionally included conditional non-cash financial incentives for linkage and retention. The primary outcome was a combined outcome of linkage to care within 1 month and retention at 12 months after diagnosis. From April 22, 2013, to June 30, 2015, we enrolled 2,004 out of 5,327 adults ≥18 years of age diagnosed with HIV in the voluntary counseling and testing clinics of participating health facilities: 744 (37%) in the CIS group, 493 (25%) in the CIS+ group, and 767 (38%) in the SOC group. Fifty-seven percent of the CIS group achieved the primary outcome versus 35% in the SOC group (relative risk [RR]CIS vs SOC = 1.58, 95% CI 1.05-2.39). Eighty-nine percent of the CIS group linked to care on the day of diagnosis versus 16% of the SOC group (RRCIS vs SOC = 9.13, 95% CI 1.65-50.40). There was no significant benefit of adding financial incentives to the CIS in terms of the combined outcome (55% of the CIS+ group achieved the primary outcome, RRCIS+ vs CIS = 0.96, 95% CI 0.81-1.16). Key limitations include the use of existing medical records to assess outcomes, the inability to isolate the effect of each component of the CIS, non-concurrent enrollment of the CIS+ group, and exclusion of many patients newly diagnosed with HIV. Conclusions: The CIS showed promise for making much needed gains in the HIV care continuum in our study, particularly in the critical first step of timely linkage to care following diagnosis. Trial registration: ClinicalTrials.gov NCT01930084.
Assuntos
Humanos , Masculino , Feminino , Adolescente , Adulto , Pessoa de Meia-Idade , Infecções por HIV/terapia , Fármacos Anti-HIV/administração & dosagem , Intervenção Médica Precoce/métodos , Terapêutica , Comportamentos Relacionados com a Saúde , Análise por Conglomerados , Infecções por HIV/diagnóstico , Epidemiologia , Seguimentos , HIV-1/efeitos dos fármacos , Cooperação do Paciente , Terapia Combinada , Motivação , MoçambiqueRESUMO
Background: Despite the extraordinary scale up of HIV prevention, care and treatment services in sub-Saharan Africa (SSA) over the past decade, the overall effectiveness of HIV programs has been significantly hindered by high levels of attrition across the HIV care continuum. Data from "real-life" settings are needed on the effectiveness of an easy to deliver package of services that can improve overall performance of the HIV care continuum. Methods/Design: We are conducting an implementation science study using a two-arm cluster site-randomized design to determine the effectiveness of a combination intervention strategy (CIS) using feasible, evidence-based, and practical interventionsincluding (1) point-of-care (POC) CD4 count testing, (2) accelerated antiretroviral therapy initiation for eligible individuals, and (3) SMS reminders for linkage to and retention in careas compared to the standard of care (SOC) in Mozambique in improving linkage and retention among adults following HIV diagnosis. A pre-post intervention two-sample design is nested within the CIS arm to assess the incremental effectiveness of the CIS plus financial incentives (CIS + FI) compared to the CIS without FI on study outcomes. Randomization is done at the level of the study site, defined as a primary health facility. Five sites are included from the City of Maputo and five from Inhambane Province. Target enrollment is a total of 2,250 adults: 750 in the SOC arm, 750 in the CIS cohort of the intervention arm and 750 in the CIS + FI cohort of the intervention arm (average of 150 participants per site). Participants are followed for 12 months from time of HIV testing to ascertain a combined endpoint of linkage to care within 1 month after testing and retention in care 12 months from HIV test. Cost-effectiveness analyses of CIS compared to SOC and CIS + FI compared to CIS will also be conducted. Discussion: Study findings will provide evidence on the effectiveness of a CIS and the incremental effectiveness of a CIS + FI in a "real-life" service delivery system in a SSA country severely impacted by HIV
Assuntos
Humanos , Masculino , Feminino , Infecções por HIV/terapia , Cooperação do Paciente , Fármacos Anti-HIV/uso terapêutico , Moçambique , Área Programática de Saúde , Infecções por HIV/diagnóstico , Infecções por HIV/imunologia , Protocolos Clínicos , Contagem de Linfócito CD4 , Fármacos Anti-HIVRESUMO
Despite recent changes to expand the ART eligibility criteria in sub-Saharan Africa, many patients still initiate ART in the advanced stages of HIV infection, which contributes to increased early mortality rates, poor patient outcomes, and onward transmission. To evaluate individual and clinic-level factors associated with late ART initiation in Mozambique, we conducted a retrospective sex-specific analysis of data from 36,411 adult patients who started ART between January 2005 and June 2009 at 25 HIV clinics in Mozambique. Late ART initiation was defined as CD4 count<100 cells/µL or WHO stage IV. Mixed effects models were used to identify patient- and clinic-level factors associated with late ART initiation. The proportion of patients initiating ART late decreased from 46% to 37% during 20052007, but remained constant (between 3733%) from 20072009. Of those who initiated ART late (median CD4â=â57 cells/µL), 5% were known to have died and 54% were lost to clinic within 6 months of ART initiation (compared with 2% and 47% among other patients starting ART [median CD4â=â192 cells/µL]). In multivariate analysis, female sex and pregnancy at ART initiation (AORfemale_not_pregnant_vs._maleâ=â0.66, 95%CI [0.620.69]; AORpregnant_vs._non_pregnantâ=â0.60, 95%CI [0.490.73]), younger and older age (AOR1525_vs.2630â=â0.86, 95%CI [0.790.94], AOR>45_vs.2630â=â0.72, 95%CI [0.670.77]), entry into care via PMTCT (AORentry_through_PMTCT_vs.VCTâ=â0.42, 95%CI [0.350.50]), marital status (AORmarried/in union_vs.singleâ=â0.87, 95%CI [0.830.92]), education (AORsecondary_or_higher_vs.primaryâ=â0.87, 95%CI [0.830.93]) and year of ART initiation were associated with a lower likelihood of late ART initiation. Clinic-level factors independently associated with a lower likelihood of late ART initiation included CD4 machine on-site (AORCD4_machine_onsite_vs.offsiteâ=â0.83, 95%CI [0.740.94]) and presence of PMTCT services onsite (AORâ=â0.85, 95%CI [0.770.93]). The risk of starting ART late remained persistently high. Efforts are needed to ensure identification and enrollment of patients at earlier stages of HIV disease. Individual and clinic level factors identified may provide clues for upstream structural interventions.
Assuntos
Humanos , Feminino , Adolescente , Adulto , Pessoa de Meia-Idade , Pacientes , Infecções por HIV , Mortalidade , Resultado do Tratamento , África Subsaariana , Transmissão Vertical de Doenças Infecciosas , AntirretroviraisRESUMO
We assessed the effect of maternal human immunodeficiency virus (HIV) infection on birth outcomes and infant survival in rural Mozambique. Pregnant women attending the antenatal clinic were recruited. These women and their infants were followed-up for one year. Birth outcomes were assessed at delivery and infant HIV status was determined at 1 and 12 months of age. Women positive for HIV were more likely to have anemia at delivery than women negative for HIV (51.3% versus 35.4%; P < 0.001). Infants born to HIV-positive mothers had a significantly higher post-neonatal mortality rate than infants born to HIV-negative mothers (7.8% versus 1.9%; P < 0.001). The rate of transmission of HIV by breastfeeding during the first year of life was 15.1% (95% confidence interval = CI 7.6-22.4). Assessment of the impact of HIV infection on birth outcomes in rural Africa is essential for tailoring public health measures to reduce mother-to-child transmission of HIV and excess infant mortality....
Assuntos
Humanos , Feminino , Recém-Nascido , Adulto , Gravidez , HIV-1 , Transmissão Vertical de Doenças Infecciosas , Carga Viral , População Rural , Mortalidade Infantil , Adolescente , Adulto , Adulto Jovem , Lactente , Moçambique/epidemiologiaRESUMO
A pesar de que los aspectos relativos a la transmisión de la infección por el VIH son bien conocidos,ésta se sigue produciendo e, incluso, aumentando en nuestro país. Las característicasde la epidemia han cambiado y hay muchas más mujeres infectadas por contacto heterosexual.En este trabajo se plantea la cuestión de la visión social de la enfermedad VIH-SIDA y surelación con la evidente dificultad para prevenirla.La metodología utilizada consistió en un análisis de contenido de la prensa escrita, fundamentalmentedurante la semana de celebración del Día Mundial del SIDA, y una entrevistagrupal semiestructurada de nueve jóvenes.La dimensión biológica (disease) de la enfermedad se aborda en pocos artículos, la dimensiónsubjetiva (illness) aparece en algunos más y la mayoría hacen referencia a la dimensión social(sickness), siendo calificada de inmunodeficiencia moral o enfermedad social dependiendodel grupo que hable sobre la misma.Los jóvenes tienen importantes lagunas de conocimientos básicos y todavía se plantean lasmismas preguntas acerca del contagio de la enfermedad que hace años y persisten algunosmitos.Lo que se sabe acerca del VIH-SIDA no se transmite eficazmente al resto de la población. Losorganismos pertinentes en la materia y algunos grupos de poder social deberían cuestionarsesu parte de responsabilidad en esto
Even though aspects relating to the transmission of HIV infection are well known, HIV infectioncontinues to be on the rise in our country. The characteristics of the epidemic havechanged and there many more women become infected through heterosexual contact. Thisarticle looks at how society views HIV-AIDS and the evident difficulty it faces to avoid it.The methodology used consisted in the analysis of the written press, mainly during the weekof the World AIDS Day and a semi-structured group interview of young individuals.The biological dimension (disease) of the cocondition is approached in several papers. Thesubjective dimension (illness) appeared in some others, while the majority of these papersmade reference to the social dimension (sickness), being classified as moral immunodeficiencyor social dimension depending on the group that spoke about such disease.Young individuals have important gaps of basic knowledge and are still looking at the samequestions about disease transmission and infection as in the past, with some myths still presentin their minds.Information on AIDS or HIV is not transmitted properly to the rest of the population. The correspondingauthorities and some groups with social power should question their share ofinvolvement and responsibility in this issue